India's Sun Pharma ups stake in Taro to 34.4 pct
MUMBAI, Feb 20 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO: Quote, Profile, Research, Stock Buzz) said on Wednesday it had bought an additional 3.7 million shares, or 9.4 percent, in Israeli generic drug maker Taro Pharmaceutical Industries Ltd TAROF.PK.
The shares, purchased by an indirect subsidiary of Sun from Brandes Investment Partners, took the stake held by Sun and its subsidiaries in Taro to 34.4 percent, it said in a statement.
Sun agreed to acquire Taro in May 2007. (Reporting by Rina Chandran; Editing by John Mair)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
District Manager - Healthcare - New York City
Details: ...Northeast Region of ARAMARK Healthcare is seeking qualified applicants...and management to company healthcare sites and service lines of...
Healthcare Center Director
Details: ...healthy.” Community Healthcare Network is a not-for-profit...immediate opening for a Healthcare Center Director at...management staff the Healthcare Center Director...
Healthcare Recruiter/Entry-Level Sales Management
Details: Maxim Healthcare Services is one...leader in the healthcare industry through...industry. Maxim Healthcare Services is recognized...
Sales - Healthcare Software / Medical Device
Details: Healthcare Technology Sales, New...area As an industry, healthcare is going through dramatic...changes. Our client, a healthcare software firm located in...
Sphere
Piracy fight
Obama skips wounded troop visit
